<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width" />
    <title>Eval Output</title>
    <style>
      body {
        font-family: -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial,
          sans-serif;
      }
      table,
      th,
      td {
        border: 1px solid black;
        border-collapse: collapse;
        text-align: left;
        word-break: break-all;
      }
      th,
      td {
        padding: 5px;
        min-width: 200px;
        white-space: pre-line;
        vertical-align: top;
      }

      tr > td[data-content^='[PASS]'] {
        color: green;
      }
      tr > td[data-content^='[FAIL]'] {
        color: #ad0000;
      }
    </style>
  </head>
  <body>
    <table>
      <thead>
        
        <th>content</th>
        
        <th>keywords</th>
        
        <th>test_description</th>
        
        <th>title</th>
        
        <th>/home/miltondp/projects/others/manubot/manubot-ai-editor-evals/introduction/prompts/baseline.txt</th>
        
        <th>/home/miltondp/projects/others/manubot/manubot-ai-editor-evals/introduction/prompts/candidate_with_metadata.txt</th>
        
        <th>/home/miltondp/projects/others/manubot/manubot-ai-editor-evals/introduction/prompts/candidate.txt</th>
        
      </thead>
      <tbody>
        
        <tr>
          
          <td data-content="Genes work together in context-specific networks to karry out different functions [@pmid:19104045; @doi:10.1038/ng.3259]. Variations in these genes can change their functional role and, at a higher level, affect disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. In this context, determining how genes influence complex traits requires mechanistically understanding ekspression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which in turn should lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies has described different regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3] including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has improoved the identification of these transcriptional mechanisms that, when dysregulated, commonly result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].">Genes work together in context-specific networks to karry out different functions [@pmid:19104045; @doi:10.1038/ng.3259]. Variations in these genes can change their functional role and, at a higher level, affect disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. In this context, determining how genes influence complex traits requires mechanistically understanding ekspression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which in turn should lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies has described different regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3] including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has improoved the identification of these transcriptional mechanisms that, when dysregulated, commonly result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].</td>
          
          <td data-content="genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits">genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits</td>
          
          <td data-content="Has no spelling errors">Has no spelling errors</td>
          
          <td data-content="Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms">Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms</td>
          
          <td data-content="[PASS] (0.50)

Genes operate in context-specific networks to perform various functions [@pmid:19104045; @doi:10.1038/ng.3259]. Alterations in these genes can modify their functional role and, on a larger scale, impact biological processes relevant to disease [@doi:10.1038/s41467-018-06022-6]. In this scenario, understanding how genes affect complex traits necessitates a mechanistic comprehension of expression regulation across diverse cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9]. This understanding should, in turn, lead to enhanced treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Prior studies have detailed various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including the genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. The integration of functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has improved the identification of transcriptional mechanisms. When these mechanisms are dysregulated, they often result in pathology specific to tissue and cell lineage [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].

Pass Reason: All assertions passed">[PASS] (0.50)

Genes operate in context-specific networks to perform various functions [@pmid:19104045; @doi:10.1038/ng.3259]. Alterations in these genes can modify their functional role and, on a larger scale, impact biological processes relevant to disease [@doi:10.1038/s41467-018-06022-6]. In this scenario, understanding how genes affect complex traits necessitates a mechanistic comprehension of expression regulation across diverse cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9]. This understanding should, in turn, lead to enhanced treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Prior studies have detailed various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including the genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. The integration of functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has improved the identification of transcriptional mechanisms. When these mechanisms are dysregulated, they often result in pathology specific to tissue and cell lineage [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].

Pass Reason: All assertions passed</td>
          
          <td data-content="[FAIL] (0.46)

Failed
---
Genes are not solitary actors but work in concert within specific networks to perform various functions [@pmid:19104045; @doi:10.1038/ng.3259]. These networks are sensitive to gene variations, which can alter the function of individual genes and, on a broader scale, influence biological processes that are relevant to diseases [@doi:10.1038/s41467-018-06022-6]. To understand how genes contribute to complex traits, it is essential to uncover the mechanisms regulating gene expression across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9]. This understanding could pave the way for the development of more effective treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Prior research has outlined various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3] and illustrated the genetic impacts on gene expression across different tissues [@doi:10.1126/science.aaz1776]. The integration of functional genomics data with GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has enhanced the identification of transcriptional mechanisms. When these mechanisms are disrupted, they often lead to pathology that is specific to certain tissues and cell lineages [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. However, a comprehensive understanding of how these transcriptional mechanisms relate to disease etiology and drug mechanisms is still lacking, which is the knowledge gap our study aims to address.

Fail Reason: Failed">[FAIL] (0.46)

Failed
---
Genes are not solitary actors but work in concert within specific networks to perform various functions [@pmid:19104045; @doi:10.1038/ng.3259]. These networks are sensitive to gene variations, which can alter the function of individual genes and, on a broader scale, influence biological processes that are relevant to diseases [@doi:10.1038/s41467-018-06022-6]. To understand how genes contribute to complex traits, it is essential to uncover the mechanisms regulating gene expression across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9]. This understanding could pave the way for the development of more effective treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Prior research has outlined various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3] and illustrated the genetic impacts on gene expression across different tissues [@doi:10.1126/science.aaz1776]. The integration of functional genomics data with GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has enhanced the identification of transcriptional mechanisms. When these mechanisms are disrupted, they often lead to pathology that is specific to certain tissues and cell lineages [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. However, a comprehensive understanding of how these transcriptional mechanisms relate to disease etiology and drug mechanisms is still lacking, which is the knowledge gap our study aims to address.

Fail Reason: Failed</td>
          
          <td data-content="[PASS] (0.50)

Genes operate within context-specific networks to perform various functions, with changes in these genes potentially altering their function and influencing disease-related biological processes [@pmid:19104045; @doi:10.1038/ng.3259; @doi:10.1038/s41467-018-06022-6]. To understand how genes contribute to complex traits, it is necessary to examine gene expression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9]. This understanding could pave the way for the development of improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous research has identified various regulatory DNA elements, including genetic effects on gene expression across diverse tissues [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3; @doi:10.1126/science.aaz1776]. The integration of functional genomics data and Genome-Wide Association Studies (GWAS) data has enhanced the identification of these transcriptional mechanisms [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890]. When these mechanisms are dysregulated, they often lead to pathology specific to certain tissues and cell lineages [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. Thus, our study aims to fill the knowledge gap in understanding the dysregulation of these transcriptional mechanisms in specific pathologies.

Pass Reason: All assertions passed">[PASS] (0.50)

Genes operate within context-specific networks to perform various functions, with changes in these genes potentially altering their function and influencing disease-related biological processes [@pmid:19104045; @doi:10.1038/ng.3259; @doi:10.1038/s41467-018-06022-6]. To understand how genes contribute to complex traits, it is necessary to examine gene expression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9]. This understanding could pave the way for the development of improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous research has identified various regulatory DNA elements, including genetic effects on gene expression across diverse tissues [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3; @doi:10.1126/science.aaz1776]. The integration of functional genomics data and Genome-Wide Association Studies (GWAS) data has enhanced the identification of these transcriptional mechanisms [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890]. When these mechanisms are dysregulated, they often lead to pathology specific to certain tissues and cell lineages [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. Thus, our study aims to fill the knowledge gap in understanding the dysregulation of these transcriptional mechanisms in specific pathologies.

Pass Reason: All assertions passed</td>
          
        </tr>
        
        <tr>
          
          <td data-content="Genes work together in context-specific networks to karry out different functions [@pmid:19104045; @doi:10.1038/ng.3259]. Variations in these genes can change their functional role and, at a higher level, affect disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. In this context, determining how genes influence complex traits requires mechanistically understanding ekspression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which in turn should lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies has described different regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3] including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has improoved the identification of these transcriptional mechanisms that, when dysregulated, commonly result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].">Genes work together in context-specific networks to karry out different functions [@pmid:19104045; @doi:10.1038/ng.3259]. Variations in these genes can change their functional role and, at a higher level, affect disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. In this context, determining how genes influence complex traits requires mechanistically understanding ekspression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which in turn should lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies has described different regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3] including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has improoved the identification of these transcriptional mechanisms that, when dysregulated, commonly result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].</td>
          
          <td data-content="genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits">genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits</td>
          
          <td data-content="Has no spelling errors">Has no spelling errors</td>
          
          <td data-content="Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms">Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms</td>
          
          <td data-content="[PASS] (0.50)

Genes operate collaboratively within context-specific networks to execute various functions [@pmid:19104045; @doi:10.1038/ng.3259]. Alterations in these genes can modify their functional roles and, on a broader scale, impact biological processes relevant to disease [@doi:10.1038/s41467-018-06022-6]. In this regard, elucidating how genes influence complex traits necessitates a mechanistic understanding of expression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9]. This understanding could eventually lead to enhanced treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies have described various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including the genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. The integration of functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has improved the identification of transcriptional mechanisms. When these mechanisms are dysregulated, they often result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].

Pass Reason: All assertions passed">[PASS] (0.50)

Genes operate collaboratively within context-specific networks to execute various functions [@pmid:19104045; @doi:10.1038/ng.3259]. Alterations in these genes can modify their functional roles and, on a broader scale, impact biological processes relevant to disease [@doi:10.1038/s41467-018-06022-6]. In this regard, elucidating how genes influence complex traits necessitates a mechanistic understanding of expression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9]. This understanding could eventually lead to enhanced treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies have described various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including the genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. The integration of functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has improved the identification of transcriptional mechanisms. When these mechanisms are dysregulated, they often result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

Genes operate in specialized networks to perform various functions, with the nature of these functions being contingent upon the context [@pmid:19104045; @doi:10.1038/ng.3259]. Alterations in these genes can modify their operational roles, which could subsequently influence biological processes that are relevant to diseases [@doi:10.1038/s41467-018-06022-6]. Consequently, to understand how genes affect complex traits, it is necessary to comprehend the regulation of gene expression across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9]. This understanding could potentially lead to the development of enhanced treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous research has outlined various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including the genetic impact on gene expression across diverse tissues [@doi:10.1126/science.aaz1776]. The integration of functional genomics data with GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has enhanced the identification of transcriptional mechanisms. When these mechanisms are disrupted, they often result in pathology specific to tissue and cell lineage [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. The gap in understanding how these mechanisms contribute to complex traits and diseases forms the crux of this study.

Pass Reason: All assertions passed">[PASS] (0.50)

Genes operate in specialized networks to perform various functions, with the nature of these functions being contingent upon the context [@pmid:19104045; @doi:10.1038/ng.3259]. Alterations in these genes can modify their operational roles, which could subsequently influence biological processes that are relevant to diseases [@doi:10.1038/s41467-018-06022-6]. Consequently, to understand how genes affect complex traits, it is necessary to comprehend the regulation of gene expression across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9]. This understanding could potentially lead to the development of enhanced treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous research has outlined various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including the genetic impact on gene expression across diverse tissues [@doi:10.1126/science.aaz1776]. The integration of functional genomics data with GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has enhanced the identification of transcriptional mechanisms. When these mechanisms are disrupted, they often result in pathology specific to tissue and cell lineage [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. The gap in understanding how these mechanisms contribute to complex traits and diseases forms the crux of this study.

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

Genes operate in unique, context-specific networks to execute varying functions, a process that has been extensively studied [@pmid:19104045; @doi:10.1038/ng.3259]. It has been observed that alterations in these genes can modify their functional roles, and consequently, impact biological processes that are pertinent to diseases [@doi:10.1038/s41467-018-06022-6]. This has led to the realization that understanding the influence of genes on complex traits necessitates a mechanistic comprehension of gene expression regulation across diverse cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], a knowledge that could potentially enhance treatment strategies [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Prior research has shed light on various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3] and the genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. The amalgamation of functional genomics data and Genome-Wide Association Studies (GWAS) data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has significantly advanced the identification of transcriptional mechanisms. When these mechanisms are dysregulated, they typically lead to tissue- and cell lineage-specific pathologies [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. However, the precise interplay between these mechanisms and disease development remains partially understood, underlining the need for further investigation.

Pass Reason: All assertions passed">[PASS] (0.50)

Genes operate in unique, context-specific networks to execute varying functions, a process that has been extensively studied [@pmid:19104045; @doi:10.1038/ng.3259]. It has been observed that alterations in these genes can modify their functional roles, and consequently, impact biological processes that are pertinent to diseases [@doi:10.1038/s41467-018-06022-6]. This has led to the realization that understanding the influence of genes on complex traits necessitates a mechanistic comprehension of gene expression regulation across diverse cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], a knowledge that could potentially enhance treatment strategies [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Prior research has shed light on various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3] and the genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. The amalgamation of functional genomics data and Genome-Wide Association Studies (GWAS) data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has significantly advanced the identification of transcriptional mechanisms. When these mechanisms are dysregulated, they typically lead to tissue- and cell lineage-specific pathologies [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. However, the precise interplay between these mechanisms and disease development remains partially understood, underlining the need for further investigation.

Pass Reason: All assertions passed</td>
          
        </tr>
        
        <tr>
          
          <td data-content="Genes work together in context-specific networks to karry out different functions [@pmid:19104045; @doi:10.1038/ng.3259]. Variations in these genes can change their functional role and, at a higher level, affect disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. In this context, determining how genes influence complex traits requires mechanistically understanding ekspression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which in turn should lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies has described different regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3] including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has improoved the identification of these transcriptional mechanisms that, when dysregulated, commonly result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].">Genes work together in context-specific networks to karry out different functions [@pmid:19104045; @doi:10.1038/ng.3259]. Variations in these genes can change their functional role and, at a higher level, affect disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. In this context, determining how genes influence complex traits requires mechanistically understanding ekspression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which in turn should lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies has described different regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3] including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has improoved the identification of these transcriptional mechanisms that, when dysregulated, commonly result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].</td>
          
          <td data-content="genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits">genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits</td>
          
          <td data-content="Has no spelling errors">Has no spelling errors</td>
          
          <td data-content="Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms">Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms</td>
          
          <td data-content="[PASS] (0.50)

Genes operate within context-specific networks to perform various functions [@pmid:19104045; @doi:10.1038/ng.3259]. Alterations in these genes can modify their functional role and, on a broader scale, impact biological processes relevant to disease [@doi:10.1038/s41467-018-06022-6]. In this scenario, understanding how genes affect complex traits necessitates a mechanistic grasp of expression regulation across diverse cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9]. This understanding should subsequently lead to enhanced treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Prior studies have detailed various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including the genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. The integration of functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has improved the identification of transcriptional mechanisms. When these mechanisms are dysregulated, they often result in pathology specific to tissue and cell lineage [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].

Pass Reason: All assertions passed">[PASS] (0.50)

Genes operate within context-specific networks to perform various functions [@pmid:19104045; @doi:10.1038/ng.3259]. Alterations in these genes can modify their functional role and, on a broader scale, impact biological processes relevant to disease [@doi:10.1038/s41467-018-06022-6]. In this scenario, understanding how genes affect complex traits necessitates a mechanistic grasp of expression regulation across diverse cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9]. This understanding should subsequently lead to enhanced treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Prior studies have detailed various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including the genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. The integration of functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has improved the identification of transcriptional mechanisms. When these mechanisms are dysregulated, they often result in pathology specific to tissue and cell lineage [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

Genes operate collaboratively within specific networks to execute various functions [@pmid:19104045; @doi:10.1038/ng.3259]. Alterations in these genes can modify their functional role and subsequently influence disease-related biological processes [@doi:10.1038/s41467-018-06022-6]. To understand this, it is essential to comprehend how genes impact complex traits through the regulation of expression across diverse cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which could potentially lead to the development of more effective treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Prior research has outlined various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including the genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. The integration of functional genomics data with GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has enhanced the identification of transcriptional mechanisms that, when disrupted, often lead to tissue- and cell lineage-specific diseases [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. However, a more comprehensive understanding of these mechanisms is needed to improve therapeutic strategies, a knowledge gap our manuscript aims to address.

Pass Reason: All assertions passed">[PASS] (0.50)

Genes operate collaboratively within specific networks to execute various functions [@pmid:19104045; @doi:10.1038/ng.3259]. Alterations in these genes can modify their functional role and subsequently influence disease-related biological processes [@doi:10.1038/s41467-018-06022-6]. To understand this, it is essential to comprehend how genes impact complex traits through the regulation of expression across diverse cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which could potentially lead to the development of more effective treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Prior research has outlined various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including the genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. The integration of functional genomics data with GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has enhanced the identification of transcriptional mechanisms that, when disrupted, often lead to tissue- and cell lineage-specific diseases [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. However, a more comprehensive understanding of these mechanisms is needed to improve therapeutic strategies, a knowledge gap our manuscript aims to address.

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

Genes interact within specific networks to perform various functions, with gene variations potentially altering their roles and impacting disease-related biological processes [@pmid:19104045; @doi:10.1038/ng.3259; @doi:10.1038/s41467-018-06022-6]. To understand how genes influence complex traits, it&#39;s necessary to delve into the regulation of gene expression across different cell types. This understanding could pave the way for enhanced treatments [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9; @doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Prior research has identified various regulatory DNA elements, including those that affect gene expression across different tissues [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3; @doi:10.1126/science.aaz1776]. By combining functional genomics data with GWAS data, researchers have improved the identification of transcriptional mechanisms. When these mechanisms are disrupted, they often lead to pathology specific to certain tissues and cell lineages [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890; @pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. This manuscript aims to further explore this intricate relationship between gene variations, expression regulation, and disease processes.

Pass Reason: All assertions passed">[PASS] (0.50)

Genes interact within specific networks to perform various functions, with gene variations potentially altering their roles and impacting disease-related biological processes [@pmid:19104045; @doi:10.1038/ng.3259; @doi:10.1038/s41467-018-06022-6]. To understand how genes influence complex traits, it's necessary to delve into the regulation of gene expression across different cell types. This understanding could pave the way for enhanced treatments [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9; @doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Prior research has identified various regulatory DNA elements, including those that affect gene expression across different tissues [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3; @doi:10.1126/science.aaz1776]. By combining functional genomics data with GWAS data, researchers have improved the identification of transcriptional mechanisms. When these mechanisms are disrupted, they often lead to pathology specific to certain tissues and cell lineages [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890; @pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. This manuscript aims to further explore this intricate relationship between gene variations, expression regulation, and disease processes.

Pass Reason: All assertions passed</td>
          
        </tr>
        
        <tr>
          
          <td data-content="Genes work together in context-specific networks to karry out different functions [@pmid:19104045; @doi:10.1038/ng.3259]. Variations in these genes can change their functional role and, at a higher level, affect disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. In this context, determining how genes influence complex traits requires mechanistically understanding ekspression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which in turn should lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies has described different regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3] including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has improoved the identification of these transcriptional mechanisms that, when dysregulated, commonly result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].">Genes work together in context-specific networks to karry out different functions [@pmid:19104045; @doi:10.1038/ng.3259]. Variations in these genes can change their functional role and, at a higher level, affect disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. In this context, determining how genes influence complex traits requires mechanistically understanding ekspression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which in turn should lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies has described different regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3] including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has improoved the identification of these transcriptional mechanisms that, when dysregulated, commonly result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].</td>
          
          <td data-content="genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits">genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits</td>
          
          <td data-content="Has no spelling errors">Has no spelling errors</td>
          
          <td data-content="Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms">Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms</td>
          
          <td data-content="[PASS] (0.50)

Genes operate collectively within context-specific networks to execute various functions. Variations within these genes can alter their functional roles and, on a broader scale, influence disease-relevant biological processes. In this context, understanding how genes affect complex traits necessitates a mechanistic comprehension of expression regulation across diverse cell types. This understanding should, in turn, facilitate the development of improved treatments. Previous studies have identified different regulatory DNA elements, including genetic effects on gene expression across various tissues. The integration of functional genomics data and GWAS data has enhanced the identification of these transcriptional mechanisms. When these mechanisms are dysregulated, they commonly result in tissue- and cell lineage-specific pathology.

Pass Reason: All assertions passed">[PASS] (0.50)

Genes operate collectively within context-specific networks to execute various functions. Variations within these genes can alter their functional roles and, on a broader scale, influence disease-relevant biological processes. In this context, understanding how genes affect complex traits necessitates a mechanistic comprehension of expression regulation across diverse cell types. This understanding should, in turn, facilitate the development of improved treatments. Previous studies have identified different regulatory DNA elements, including genetic effects on gene expression across various tissues. The integration of functional genomics data and GWAS data has enhanced the identification of these transcriptional mechanisms. When these mechanisms are dysregulated, they commonly result in tissue- and cell lineage-specific pathology.

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

Genes do not operate in isolation but work synergistically within context-specific networks to perform various functions [@pmid:19104045; @doi:10.1038/ng.3259]. Alterations within these genes can modify their operational role and subsequently influence biological processes that are relevant to disease manifestation [@doi:10.1038/s41467-018-06022-6]. To comprehend how genes impact complex traits, it is crucial to explore the regulation of gene expression across diverse cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9] -- a deeper understanding of this could pave the way for more effective treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous research has shed light on various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including the influence of genetic variations on gene expression across different tissues [@doi:10.1126/science.aaz1776]. By merging information from functional genomics and genome-wide association studies (GWAS) [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890], the identification of transcriptional mechanisms has been significantly improved. When these mechanisms are disrupted, they often lead to tissue- and cell lineage-specific diseases [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. This underscores the importance of our study, which seeks to further elucidate these intricate gene-disease relationships and their potential implications for therapeutic intervention.

Pass Reason: All assertions passed">[PASS] (0.50)

Genes do not operate in isolation but work synergistically within context-specific networks to perform various functions [@pmid:19104045; @doi:10.1038/ng.3259]. Alterations within these genes can modify their operational role and subsequently influence biological processes that are relevant to disease manifestation [@doi:10.1038/s41467-018-06022-6]. To comprehend how genes impact complex traits, it is crucial to explore the regulation of gene expression across diverse cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9] -- a deeper understanding of this could pave the way for more effective treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous research has shed light on various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including the influence of genetic variations on gene expression across different tissues [@doi:10.1126/science.aaz1776]. By merging information from functional genomics and genome-wide association studies (GWAS) [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890], the identification of transcriptional mechanisms has been significantly improved. When these mechanisms are disrupted, they often lead to tissue- and cell lineage-specific diseases [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. This underscores the importance of our study, which seeks to further elucidate these intricate gene-disease relationships and their potential implications for therapeutic intervention.

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

Genes operate in tandem within context-specific networks to execute various functions, a process that is central to our understanding of biological systems [@pmid:19104045; @doi:10.1038/ng.3259]. These genes are not static entities; variations within them can alter their functional roles, and on a broader scale, impact biological processes that are relevant to disease [@doi:10.1038/s41467-018-06022-6]. To fully appreciate how genes contribute to complex traits, we need to delve into the mechanisms of gene expression regulation across diverse cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9]. This knowledge could pave the way for the development of more effective treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Prior research has illuminated various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including those that influence gene expression across different tissues [@doi:10.1126/science.aaz1776]. The integration of functional genomics data with Genome-Wide Association Studies (GWAS) data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has enhanced our ability to identify transcriptional mechanisms. When these mechanisms are disrupted, they often lead to pathology that is specific to certain tissues and cell lineages [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].

Pass Reason: All assertions passed">[PASS] (0.50)

Genes operate in tandem within context-specific networks to execute various functions, a process that is central to our understanding of biological systems [@pmid:19104045; @doi:10.1038/ng.3259]. These genes are not static entities; variations within them can alter their functional roles, and on a broader scale, impact biological processes that are relevant to disease [@doi:10.1038/s41467-018-06022-6]. To fully appreciate how genes contribute to complex traits, we need to delve into the mechanisms of gene expression regulation across diverse cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9]. This knowledge could pave the way for the development of more effective treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Prior research has illuminated various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including those that influence gene expression across different tissues [@doi:10.1126/science.aaz1776]. The integration of functional genomics data with Genome-Wide Association Studies (GWAS) data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has enhanced our ability to identify transcriptional mechanisms. When these mechanisms are disrupted, they often lead to pathology that is specific to certain tissues and cell lineages [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].

Pass Reason: All assertions passed</td>
          
        </tr>
        
        <tr>
          
          <td data-content="Genes work together in context-specific networks to karry out different functions [@pmid:19104045; @doi:10.1038/ng.3259]. Variations in these genes can change their functional role and, at a higher level, affect disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. In this context, determining how genes influence complex traits requires mechanistically understanding ekspression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which in turn should lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies has described different regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3] including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has improoved the identification of these transcriptional mechanisms that, when dysregulated, commonly result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].">Genes work together in context-specific networks to karry out different functions [@pmid:19104045; @doi:10.1038/ng.3259]. Variations in these genes can change their functional role and, at a higher level, affect disease-relevant biological processes [@doi:10.1038/s41467-018-06022-6]. In this context, determining how genes influence complex traits requires mechanistically understanding ekspression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], which in turn should lead to improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies has described different regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3] including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. Integrating functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has improoved the identification of these transcriptional mechanisms that, when dysregulated, commonly result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].</td>
          
          <td data-content="genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits">genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits</td>
          
          <td data-content="Has no spelling errors">Has no spelling errors</td>
          
          <td data-content="Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms">Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms</td>
          
          <td data-content="[PASS] (0.50)

Genes operate in context-specific networks to perform various functions [@pmid:19104045; @doi:10.1038/ng.3259]. Alterations in these genes can modify their functional roles and, on a broader scale, can impact biological processes relevant to disease [@doi:10.1038/s41467-018-06022-6]. In this regard, understanding how genes affect complex traits necessitates a mechanistic comprehension of expression regulation across various cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9]. This understanding should subsequently lead to the development of enhanced treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies have described various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. The integration of functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has improved the identification of these transcriptional mechanisms. When these mechanisms are dysregulated, they often result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].

Pass Reason: All assertions passed">[PASS] (0.50)

Genes operate in context-specific networks to perform various functions [@pmid:19104045; @doi:10.1038/ng.3259]. Alterations in these genes can modify their functional roles and, on a broader scale, can impact biological processes relevant to disease [@doi:10.1038/s41467-018-06022-6]. In this regard, understanding how genes affect complex traits necessitates a mechanistic comprehension of expression regulation across various cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9]. This understanding should subsequently lead to the development of enhanced treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous studies have described various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3], including genetic effects on gene expression across different tissues [@doi:10.1126/science.aaz1776]. The integration of functional genomics data and GWAS data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has improved the identification of these transcriptional mechanisms. When these mechanisms are dysregulated, they often result in tissue- and cell lineage-specific pathology [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105].

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

Genes operate in specific networks to perform various functions, and alterations in these genes can modify their function and impact biological processes relevant to diseases [@pmid:19104045; @doi:10.1038/ng.3259; @doi:10.1038/s41467-018-06022-6]. To understand how genes contribute to complex traits, it is essential to grasp the regulation of gene expression across different cell types, which is expected to lead to the development of improved treatments [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9; @doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous research has identified various regulatory DNA elements and the genetic effects on gene expression across different tissues [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3; @doi:10.1126/science.aaz1776]. The integration of functional genomics data with GWAS data has enhanced the identification of transcriptional mechanisms, which, when disrupted, often lead to pathology specific to tissue and cell lineage [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890; @pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. Despite these advancements, a comprehensive understanding of how these genetic variations influence disease development and drug response remains incomplete, a gap this manuscript aims to address.

Pass Reason: All assertions passed">[PASS] (0.50)

Genes operate in specific networks to perform various functions, and alterations in these genes can modify their function and impact biological processes relevant to diseases [@pmid:19104045; @doi:10.1038/ng.3259; @doi:10.1038/s41467-018-06022-6]. To understand how genes contribute to complex traits, it is essential to grasp the regulation of gene expression across different cell types, which is expected to lead to the development of improved treatments [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9; @doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Previous research has identified various regulatory DNA elements and the genetic effects on gene expression across different tissues [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3; @doi:10.1126/science.aaz1776]. The integration of functional genomics data with GWAS data has enhanced the identification of transcriptional mechanisms, which, when disrupted, often lead to pathology specific to tissue and cell lineage [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890; @pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. Despite these advancements, a comprehensive understanding of how these genetic variations influence disease development and drug response remains incomplete, a gap this manuscript aims to address.

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

Genes operate within specific networks to perform various functions, a principle well-established in the literature [@pmid:19104045; @doi:10.1038/ng.3259]. Changes or variations within these genes can alter their functional roles, subsequently impacting biological processes relevant to diseases [@doi:10.1038/s41467-018-06022-6]. The complexity of these gene interactions necessitates a mechanistic understanding of gene expression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], a comprehension that may pave the way for the development of improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Prior research has outlined various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3] and explored genetic effects on gene expression across diverse tissues [@doi:10.1126/science.aaz1776]. The integration of functional genomics data with Genome-Wide Association Studies (GWAS) data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has enhanced the identification of transcriptional mechanisms. When these mechanisms are disrupted, they often lead to tissue- and cell lineage-specific diseases [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. However, the intricacies of these transcriptional mechanisms remain to be fully understood, which is the knowledge gap this manuscript aims to address.

Pass Reason: All assertions passed">[PASS] (0.50)

Genes operate within specific networks to perform various functions, a principle well-established in the literature [@pmid:19104045; @doi:10.1038/ng.3259]. Changes or variations within these genes can alter their functional roles, subsequently impacting biological processes relevant to diseases [@doi:10.1038/s41467-018-06022-6]. The complexity of these gene interactions necessitates a mechanistic understanding of gene expression regulation across different cell types [@doi:10.1126/science.aaz1776; @doi:10.1038/s41586-020-2559-3; @doi:10.1038/s41576-019-0200-9], a comprehension that may pave the way for the development of improved treatments [@doi:10.1038/ng.3314; @doi:10.1371/journal.pgen.1008489]. Prior research has outlined various regulatory DNA elements [@doi:10.1038/nature11247; @doi:10.1038/nature14248; @doi:10.1038/nature12787; @doi:10.1038/s41586-020-03145-z; @doi:10.1038/s41586-020-2559-3] and explored genetic effects on gene expression across diverse tissues [@doi:10.1126/science.aaz1776]. The integration of functional genomics data with Genome-Wide Association Studies (GWAS) data [@doi:10.1038/s41588-018-0081-4; @doi:10.1016/j.ajhg.2018.04.002; @doi:10.1038/s41588-018-0081-4; @doi:10.1038/ncomms6890] has enhanced the identification of transcriptional mechanisms. When these mechanisms are disrupted, they often lead to tissue- and cell lineage-specific diseases [@pmid:20624743; @pmid:14707169; @doi:10.1073/pnas.0810772105]. However, the intricacies of these transcriptional mechanisms remain to be fully understood, which is the knowledge gap this manuscript aims to address.

Pass Reason: All assertions passed</td>
          
        </tr>
        
        <tr>
          
          <td data-content="Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.">Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.</td>
          
          <td data-content="genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits">genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits</td>
          
          <td data-content="Keeps most references to other articles and doesn&#39;t make them up">Keeps most references to other articles and doesn't make them up</td>
          
          <td data-content="Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms">Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms</td>
          
          <td data-content="[FAIL] (0.44)

Failed
---
The availability of gene expression data across various tissues has paved the way for innovative approaches to identify biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1038/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. One such approach, the transcription-wide association study (TWAS), integrates expression quantitative trait loci (eQTLs) data to interpret the mechanistic underpinnings of genome-wide association study (GWAS) findings. This method hinges on the examination of how disruptions in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These approaches have proven highly effective not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618]. However, TWAS operates at the individual gene level, thereby failing to capture more intricate interactions at the network level.

Fail Reason: Failed">[FAIL] (0.44)

Failed
---
The availability of gene expression data across various tissues has paved the way for innovative approaches to identify biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1038/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. One such approach, the transcription-wide association study (TWAS), integrates expression quantitative trait loci (eQTLs) data to interpret the mechanistic underpinnings of genome-wide association study (GWAS) findings. This method hinges on the examination of how disruptions in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These approaches have proven highly effective not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618]. However, TWAS operates at the individual gene level, thereby failing to capture more intricate interactions at the network level.

Fail Reason: Failed</td>
          
          <td data-content="[PASS] (0.69)

The increasing accessibility of gene expression data across various tissues has opened new avenues for understanding disease processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1038/ng.3367]. One such avenue is the Transcription-Wide Association Study (TWAS), a method that combines expression quantitative trait loci (eQTLs) data to interpret the results of Genome-Wide Association Studies (GWAS) in terms of biological mechanisms. TWAS operates by testing whether changes in gene regulation mechanisms can explain the link between genetic variations and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889]. This approach has proven successful in elucidating disease causes at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], predicting disease risk using polygenic scores [@doi:10.1186/s13059-021-02591-w], and repurposing drugs [@doi:10.1038/nn.4618]. However, the current application of TWAS, which focuses on individual genes, fails to take into account the potentially more intricate network-level interactions. This study aims to address this limitation, offering a more comprehensive understanding of disease etiology and drug mechanisms.

Pass Reason: All assertions passed">[PASS] (0.69)

The increasing accessibility of gene expression data across various tissues has opened new avenues for understanding disease processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1038/ng.3367]. One such avenue is the Transcription-Wide Association Study (TWAS), a method that combines expression quantitative trait loci (eQTLs) data to interpret the results of Genome-Wide Association Studies (GWAS) in terms of biological mechanisms. TWAS operates by testing whether changes in gene regulation mechanisms can explain the link between genetic variations and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889]. This approach has proven successful in elucidating disease causes at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], predicting disease risk using polygenic scores [@doi:10.1186/s13059-021-02591-w], and repurposing drugs [@doi:10.1038/nn.4618]. However, the current application of TWAS, which focuses on individual genes, fails to take into account the potentially more intricate network-level interactions. This study aims to address this limitation, offering a more comprehensive understanding of disease etiology and drug mechanisms.

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.69)

With the wealth of gene expression data available across a range of tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], researchers have been able to identify key biological processes. One of the most effective methods for this purpose is the transcription-wide association study (TWAS). TWAS integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation of genome-wide association study (GWAS) findings. It does this by examining whether changes in gene regulation mechanisms can explain the link between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has proven to be highly successful, enhancing our understanding of disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], improving disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w], and facilitating drug repurposing [@doi:10.1038/nn.4618]. However, a significant knowledge gap remains as TWAS operates at the level of individual genes, thereby failing to capture more complex interactions at the network level.

Pass Reason: All assertions passed">[PASS] (0.69)

With the wealth of gene expression data available across a range of tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], researchers have been able to identify key biological processes. One of the most effective methods for this purpose is the transcription-wide association study (TWAS). TWAS integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation of genome-wide association study (GWAS) findings. It does this by examining whether changes in gene regulation mechanisms can explain the link between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has proven to be highly successful, enhancing our understanding of disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], improving disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w], and facilitating drug repurposing [@doi:10.1038/nn.4618]. However, a significant knowledge gap remains as TWAS operates at the level of individual genes, thereby failing to capture more complex interactions at the network level.

Pass Reason: All assertions passed</td>
          
        </tr>
        
        <tr>
          
          <td data-content="Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.">Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.</td>
          
          <td data-content="genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits">genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits</td>
          
          <td data-content="Keeps most references to other articles and doesn&#39;t make them up">Keeps most references to other articles and doesn't make them up</td>
          
          <td data-content="Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms">Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms</td>
          
          <td data-content="[PASS] (0.69)

The availability of gene expression data across various tissues provides an effective approach to identify biological processes through the use of transcription-wide association studies (TWAS) [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. This technique integrates expression quantitative trait loci (eQTLs) data to offer a mechanistic interpretation of Genome-Wide Association Study (GWAS) findings. The TWAS method involves testing whether disturbances in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has proven highly successful, not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and in drug repurposing [@doi:10.1038/nn.4618]. However, TWAS primarily operates at the individual gene level, thereby failing to capture more complex interactions at the network level.

Pass Reason: All assertions passed">[PASS] (0.69)

The availability of gene expression data across various tissues provides an effective approach to identify biological processes through the use of transcription-wide association studies (TWAS) [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. This technique integrates expression quantitative trait loci (eQTLs) data to offer a mechanistic interpretation of Genome-Wide Association Study (GWAS) findings. The TWAS method involves testing whether disturbances in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has proven highly successful, not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and in drug repurposing [@doi:10.1038/nn.4618]. However, TWAS primarily operates at the individual gene level, thereby failing to capture more complex interactions at the network level.

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.69)

The surge in available gene expression data across various tissues has opened up new avenues for understanding biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1038/ng.3367] (Context). A prominent method for deciphering these processes is the transcription-wide association study (TWAS) that utilizes expression quantitative trait loci (eQTLs) data to interpret the findings of Genome-Wide Association Studies (GWAS) in a mechanistic context. This approach tests the hypothesis that changes in gene regulatory mechanisms can explain the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889]. This strategy has proven effective not only in understanding disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618] (Content). However, a limitation of TWAS is that it operates at the level of individual genes, thereby failing to account for more intricate interactions occurring at the network level (Conclusion).

Pass Reason: All assertions passed">[PASS] (0.69)

The surge in available gene expression data across various tissues has opened up new avenues for understanding biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1038/ng.3367] (Context). A prominent method for deciphering these processes is the transcription-wide association study (TWAS) that utilizes expression quantitative trait loci (eQTLs) data to interpret the findings of Genome-Wide Association Studies (GWAS) in a mechanistic context. This approach tests the hypothesis that changes in gene regulatory mechanisms can explain the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889]. This strategy has proven effective not only in understanding disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618] (Content). However, a limitation of TWAS is that it operates at the level of individual genes, thereby failing to account for more intricate interactions occurring at the network level (Conclusion).

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.69)

The extensive availability of gene expression data across various tissues has opened new avenues for understanding the mechanisms of biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. One such promising method is the Transcription-Wide Association Study (TWAS), which leverages expression quantitative trait loci (eQTLs) data to give mechanistic insights into the findings of Genome-Wide Association Studies (GWAS). This approach involves examining the role of gene regulatory changes in the relationship between genetic variations and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. Its success has been demonstrated not only in elucidating disease origin at the gene expression level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618]. Despite these achievements, a significant limitation of TWAS is its focus on individual genes, neglecting the potential complexity of interactions at the network level. This points to an area of potential further study and refinement in the TWAS methodology.

Pass Reason: All assertions passed">[PASS] (0.69)

The extensive availability of gene expression data across various tissues has opened new avenues for understanding the mechanisms of biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. One such promising method is the Transcription-Wide Association Study (TWAS), which leverages expression quantitative trait loci (eQTLs) data to give mechanistic insights into the findings of Genome-Wide Association Studies (GWAS). This approach involves examining the role of gene regulatory changes in the relationship between genetic variations and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. Its success has been demonstrated not only in elucidating disease origin at the gene expression level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618]. Despite these achievements, a significant limitation of TWAS is its focus on individual genes, neglecting the potential complexity of interactions at the network level. This points to an area of potential further study and refinement in the TWAS methodology.

Pass Reason: All assertions passed</td>
          
        </tr>
        
        <tr>
          
          <td data-content="Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.">Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.</td>
          
          <td data-content="genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits">genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits</td>
          
          <td data-content="Keeps most references to other articles and doesn&#39;t make them up">Keeps most references to other articles and doesn't make them up</td>
          
          <td data-content="Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms">Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms</td>
          
          <td data-content="[FAIL] (0.44)

Failed
---
Given the widespread availability of gene expression data across various tissues, the transcription-wide association study (TWAS) has emerged as an effective approach to identify biological processes. This strategy integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation of Genome-Wide Association Study (GWAS) findings. TWAS examines whether disruptions in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases. These methods have proven highly successful, not only in understanding disease etiology at the transcriptome level but also in predicting disease risk through polygenic scores and facilitating drug repurposing. However, one limitation of TWAS is its focus on individual gene levels, which may overlook more complex interactions at the network level.

Fail Reason: Failed">[FAIL] (0.44)

Failed
---
Given the widespread availability of gene expression data across various tissues, the transcription-wide association study (TWAS) has emerged as an effective approach to identify biological processes. This strategy integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation of Genome-Wide Association Study (GWAS) findings. TWAS examines whether disruptions in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases. These methods have proven highly successful, not only in understanding disease etiology at the transcriptome level but also in predicting disease risk through polygenic scores and facilitating drug repurposing. However, one limitation of TWAS is its focus on individual gene levels, which may overlook more complex interactions at the network level.

Fail Reason: Failed</td>
          
          <td data-content="[PASS] (0.69)

The burgeoning availability of gene expression data across various tissues has opened new avenues for understanding biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9] (Context). One such avenue is the transcription-wide association study (TWAS), a method that incorporates expression quantitative trait loci (eQTLs) data to elucidate the mechanisms behind genome-wide association study (GWAS) findings. This approach hinges on the idea that disruptions in gene regulatory mechanisms could be the bridge between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This has not only been successful in gaining insights into disease causation at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618] (Content). However, the current TWAS model operates at the level of individual genes, and as such, it falls short in capturing the complexity of interactions that occur at the network level (Conclusion).

Pass Reason: All assertions passed">[PASS] (0.69)

The burgeoning availability of gene expression data across various tissues has opened new avenues for understanding biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9] (Context). One such avenue is the transcription-wide association study (TWAS), a method that incorporates expression quantitative trait loci (eQTLs) data to elucidate the mechanisms behind genome-wide association study (GWAS) findings. This approach hinges on the idea that disruptions in gene regulatory mechanisms could be the bridge between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This has not only been successful in gaining insights into disease causation at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618] (Content). However, the current TWAS model operates at the level of individual genes, and as such, it falls short in capturing the complexity of interactions that occur at the network level (Conclusion).

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.69)

The extensive availability of gene expression data across various tissues presents an opportunity to identify and examine biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. One effective method for this investigation is the transcription-wide association study (TWAS), which utilizes expression quantitative trait loci (eQTLs) data to interpret the mechanisms behind findings from genome-wide association studies (GWAS). This approach tests the hypothesis that changes in gene regulation could mediate the relationship between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. The success of TWAS has been demonstrated in understanding disease causes at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], predicting disease risks (using polygenic scores) [@doi:10.1186/s13059-021-02591-w], and repurposing drugs [@doi:10.1038/nn.4618]. However, a limitation of TWAS is that it operates at the level of individual genes, thereby failing to capture the complexity of interactions at the network level. This manuscript aims to address this knowledge gap and explore network-level interactions.

Pass Reason: All assertions passed">[PASS] (0.69)

The extensive availability of gene expression data across various tissues presents an opportunity to identify and examine biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. One effective method for this investigation is the transcription-wide association study (TWAS), which utilizes expression quantitative trait loci (eQTLs) data to interpret the mechanisms behind findings from genome-wide association studies (GWAS). This approach tests the hypothesis that changes in gene regulation could mediate the relationship between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. The success of TWAS has been demonstrated in understanding disease causes at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], predicting disease risks (using polygenic scores) [@doi:10.1186/s13059-021-02591-w], and repurposing drugs [@doi:10.1038/nn.4618]. However, a limitation of TWAS is that it operates at the level of individual genes, thereby failing to capture the complexity of interactions at the network level. This manuscript aims to address this knowledge gap and explore network-level interactions.

Pass Reason: All assertions passed</td>
          
        </tr>
        
        <tr>
          
          <td data-content="Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.">Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.</td>
          
          <td data-content="genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits">genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits</td>
          
          <td data-content="Keeps most references to other articles and doesn&#39;t make them up">Keeps most references to other articles and doesn't make them up</td>
          
          <td data-content="Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms">Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms</td>
          
          <td data-content="[PASS] (0.69)

The extensive availability of gene expression data across various tissues allows for the identification of biological processes through the use of transcription-wide association studies (TWAS) [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. This method integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation of GWAS findings. TWAS operates by testing if alterations in gene regulatory mechanisms serve as a mediator in the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has proven to be highly successful in not only understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618]. Nonetheless, TWAS has limitations as it operates at the individual gene level, thus failing to capture more complex interactions at the network level.

Pass Reason: All assertions passed">[PASS] (0.69)

The extensive availability of gene expression data across various tissues allows for the identification of biological processes through the use of transcription-wide association studies (TWAS) [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. This method integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation of GWAS findings. TWAS operates by testing if alterations in gene regulatory mechanisms serve as a mediator in the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has proven to be highly successful in not only understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618]. Nonetheless, TWAS has limitations as it operates at the individual gene level, thus failing to capture more complex interactions at the network level.

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.69)

With an abundance of gene expression data now available across a variety of tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1038/ng.3367], scientists are able to employ transcription-wide association studies (TWAS) to identify key biological processes. This innovative approach integrates data from expression quantitative trait loci (eQTLs) to provide a mechanistic explanation for findings from genome-wide association studies (GWAS). The core of TWAS lies in examining if changes in gene regulatory mechanisms serve as the link between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889]. This method has proven to be highly effective not just in understanding the origins of diseases at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk through polygenic scores [@doi:10.1186/s13059-021-02591-w] and identifying new uses for existing drugs [@doi:10.1038/nn.4618]. However, while TWAS offers valuable insights, it focuses on individual genes and thus falls short in capturing the more intricate interactions occurring at the network level. This study aims to address this gap by exploring these complex interactions.

Pass Reason: All assertions passed">[PASS] (0.69)

With an abundance of gene expression data now available across a variety of tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1038/ng.3367], scientists are able to employ transcription-wide association studies (TWAS) to identify key biological processes. This innovative approach integrates data from expression quantitative trait loci (eQTLs) to provide a mechanistic explanation for findings from genome-wide association studies (GWAS). The core of TWAS lies in examining if changes in gene regulatory mechanisms serve as the link between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889]. This method has proven to be highly effective not just in understanding the origins of diseases at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk through polygenic scores [@doi:10.1186/s13059-021-02591-w] and identifying new uses for existing drugs [@doi:10.1038/nn.4618]. However, while TWAS offers valuable insights, it focuses on individual genes and thus falls short in capturing the more intricate interactions occurring at the network level. This study aims to address this gap by exploring these complex interactions.

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.69)

The vast amount of gene expression data available across various tissues provides a unique opportunity to uncover the biological processes underlying human diseases [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. Transcription-wide association studies (TWAS) have emerged as an effective approach to leverage this data, integrating expression quantitative trait loci (eQTLs) to interpret the findings of genome-wide association studies (GWAS). This method tests the hypothesis that changes in gene regulation mechanisms can explain the link between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. TWAS has proven successful in enhancing our understanding of disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], predicting disease risk through polygenic scores [@doi:10.1186/s13059-021-02591-w], and repurposing drugs [@doi:10.1038/nn.4618]. However, the current TWAS approach primarily focuses on individual genes, thereby overlooking the potential for more intricate interactions at the network level. This highlights a knowledge gap that the present manuscript aims to address.

Pass Reason: All assertions passed">[PASS] (0.69)

The vast amount of gene expression data available across various tissues provides a unique opportunity to uncover the biological processes underlying human diseases [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. Transcription-wide association studies (TWAS) have emerged as an effective approach to leverage this data, integrating expression quantitative trait loci (eQTLs) to interpret the findings of genome-wide association studies (GWAS). This method tests the hypothesis that changes in gene regulation mechanisms can explain the link between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. TWAS has proven successful in enhancing our understanding of disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], predicting disease risk through polygenic scores [@doi:10.1186/s13059-021-02591-w], and repurposing drugs [@doi:10.1038/nn.4618]. However, the current TWAS approach primarily focuses on individual genes, thereby overlooking the potential for more intricate interactions at the network level. This highlights a knowledge gap that the present manuscript aims to address.

Pass Reason: All assertions passed</td>
          
        </tr>
        
        <tr>
          
          <td data-content="Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.">Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.</td>
          
          <td data-content="genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits">genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits</td>
          
          <td data-content="Keeps most references to other articles and doesn&#39;t make them up">Keeps most references to other articles and doesn't make them up</td>
          
          <td data-content="Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms">Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms</td>
          
          <td data-content="[PASS] (0.69)

The availability of gene expression data across numerous tissues has paved the way for advanced strategies to identify biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. One such effective approach is the transcription-wide association study (TWAS), which utilizes expression quantitative trait loci (eQTLs) data to offer a mechanistic interpretation of GWAS findings. TWAS is based on the assessment of whether alterations in gene regulatory mechanisms serve as a mediator in the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This method has proven highly successful in not only understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease-risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618]. However, a limitation of TWAS is that it operates at the individual gene level and does not account for more complex interactions at the network level.

Pass Reason: All assertions passed">[PASS] (0.69)

The availability of gene expression data across numerous tissues has paved the way for advanced strategies to identify biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. One such effective approach is the transcription-wide association study (TWAS), which utilizes expression quantitative trait loci (eQTLs) data to offer a mechanistic interpretation of GWAS findings. TWAS is based on the assessment of whether alterations in gene regulatory mechanisms serve as a mediator in the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This method has proven highly successful in not only understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease-risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618]. However, a limitation of TWAS is that it operates at the individual gene level and does not account for more complex interactions at the network level.

Pass Reason: All assertions passed</td>
          
          <td data-content="[FAIL] (0.44)

Failed
---
The advent of gene expression data across various tissues has opened new avenues in genetic studies [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1038/s1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9] (Context). A promising method to explore these biological processes is the transcription-wide association study (TWAS), which unites expression quantitative trait loci (eQTLs) data to offer mechanistic explanations for genome-wide association study (GWAS) results. TWAS investigates how changes in gene regulation could explain the relationship between genetic variations and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This method has proven highly successful in not only enhancing our understanding of disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and identifying new uses for existing drugs (drug repurposing) [@doi:10.1038/nn.4618] (Content). However, the limitation of TWAS is that it operates at the individual gene level, thus it fails to capture the more intricate interactions that occur at the network level, a knowledge gap this manuscript aims to address (Conclusion).

Fail Reason: Failed">[FAIL] (0.44)

Failed
---
The advent of gene expression data across various tissues has opened new avenues in genetic studies [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1038/s1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9] (Context). A promising method to explore these biological processes is the transcription-wide association study (TWAS), which unites expression quantitative trait loci (eQTLs) data to offer mechanistic explanations for genome-wide association study (GWAS) results. TWAS investigates how changes in gene regulation could explain the relationship between genetic variations and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This method has proven highly successful in not only enhancing our understanding of disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and identifying new uses for existing drugs (drug repurposing) [@doi:10.1038/nn.4618] (Content). However, the limitation of TWAS is that it operates at the individual gene level, thus it fails to capture the more intricate interactions that occur at the network level, a knowledge gap this manuscript aims to address (Conclusion).

Fail Reason: Failed</td>
          
          <td data-content="[PASS] (0.69)

The advent of gene expression data across various tissues has opened up new avenues for understanding biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. A key tool in this endeavor is the transcription-wide association study (TWAS), which leverages expression quantitative trait loci (eQTLs) data to shed light on the mechanisms underlying genome-wide association study (GWAS) findings. Specifically, TWAS examines whether changes in gene regulation mechanisms can explain the relationship between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has proven highly successful in elucidating disease causes at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], predicting disease risk (via polygenic scores) [@doi:10.1186/s13059-021-02591-w], and repurposing drugs [@doi:10.1038/nn.4618]. However, despite its successes, TWAS operates at the level of individual genes and therefore fails to capture more intricate interactions that occur at the network level.

Pass Reason: All assertions passed">[PASS] (0.69)

The advent of gene expression data across various tissues has opened up new avenues for understanding biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. A key tool in this endeavor is the transcription-wide association study (TWAS), which leverages expression quantitative trait loci (eQTLs) data to shed light on the mechanisms underlying genome-wide association study (GWAS) findings. Specifically, TWAS examines whether changes in gene regulation mechanisms can explain the relationship between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has proven highly successful in elucidating disease causes at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], predicting disease risk (via polygenic scores) [@doi:10.1186/s13059-021-02591-w], and repurposing drugs [@doi:10.1038/nn.4618]. However, despite its successes, TWAS operates at the level of individual genes and therefore fails to capture more intricate interactions that occur at the network level.

Pass Reason: All assertions passed</td>
          
        </tr>
        
        <tr>
          
          <td data-content="TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.">TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.</td>
          
          <td data-content="genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits">genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits</td>
          
          <td data-content="starts with context">starts with context</td>
          
          <td data-content="Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms">Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms</td>
          
          <td data-content="[PASS] (0.50)

Transcription-Wide Association Studies (TWAS) hinge on the examination of perturbations in gene regulatory mechanisms to determine their role in mediating the association between genetic variants and human diseases. These approaches have demonstrated considerable success in not only elucidating disease etiology at the transcriptome level, but also in predicting disease risk using polygenic scores and facilitating drug repurposing tasks. The widespread availability of gene expression data across multiple tissues has made TWAS a particularly effective approach to identifying these biological processes. This method integrates Expression Quantitative Trait Loci (eQTLs) data, thereby providing a mechanistic interpretation for Genome-Wide Association Studies (GWAS) findings. However, it&#39;s worth noting that TWAS operates at the individual gene level, and as such, may not capture more intricate interactions occurring at the network level.

Pass Reason: All assertions passed">[PASS] (0.50)

Transcription-Wide Association Studies (TWAS) hinge on the examination of perturbations in gene regulatory mechanisms to determine their role in mediating the association between genetic variants and human diseases. These approaches have demonstrated considerable success in not only elucidating disease etiology at the transcriptome level, but also in predicting disease risk using polygenic scores and facilitating drug repurposing tasks. The widespread availability of gene expression data across multiple tissues has made TWAS a particularly effective approach to identifying these biological processes. This method integrates Expression Quantitative Trait Loci (eQTLs) data, thereby providing a mechanistic interpretation for Genome-Wide Association Studies (GWAS) findings. However, it's worth noting that TWAS operates at the individual gene level, and as such, may not capture more intricate interactions occurring at the network level.

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

Transcription-wide association studies (TWAS) serve as a crucial tool for examining how disruptions in gene regulation may link genetic variations to human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367] (Context). These studies have proven highly effective not only for understanding disease origins at the genetic level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also for predicting disease risks (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and identifying new uses for existing drugs [@doi:10.1038/nn.4618]. The availability of gene expression data across several tissues further enhances the efficacy of TWAS [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9] (Content). However, the current scope of TWAS, which focuses on individual genes, falls short in capturing the more intricate interactions that occur at the network level, indicating a gap in our understanding of complex genetic interactions (Conclusion).

Pass Reason: All assertions passed">[PASS] (0.50)

Transcription-wide association studies (TWAS) serve as a crucial tool for examining how disruptions in gene regulation may link genetic variations to human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367] (Context). These studies have proven highly effective not only for understanding disease origins at the genetic level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also for predicting disease risks (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and identifying new uses for existing drugs [@doi:10.1038/nn.4618]. The availability of gene expression data across several tissues further enhances the efficacy of TWAS [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9] (Content). However, the current scope of TWAS, which focuses on individual genes, falls short in capturing the more intricate interactions that occur at the network level, indicating a gap in our understanding of complex genetic interactions (Conclusion).

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

Transcription-wide association studies (TWAS) serve as a critical tool in investigating the interplay between genetic variations and human diseases by examining disruptions in gene regulation mechanisms [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This method has proven successful in deciphering disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], predicting disease risk through polygenic scores [@doi:10.1186/s13059-021-02591-w], and repurposing drugs [@doi:10.1038/nn.4618]. The availability of gene expression data across numerous tissues further enhances the effectiveness of TWAS [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. However, one limitation of TWAS is its focus on individual genes, which overlooks potential complex interactions at the network level. This manuscript aims to address this knowledge gap and enhance our understanding of genetic interactions and their implications for disease progression.

Pass Reason: All assertions passed">[PASS] (0.50)

Transcription-wide association studies (TWAS) serve as a critical tool in investigating the interplay between genetic variations and human diseases by examining disruptions in gene regulation mechanisms [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This method has proven successful in deciphering disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], predicting disease risk through polygenic scores [@doi:10.1186/s13059-021-02591-w], and repurposing drugs [@doi:10.1038/nn.4618]. The availability of gene expression data across numerous tissues further enhances the effectiveness of TWAS [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. However, one limitation of TWAS is its focus on individual genes, which overlooks potential complex interactions at the network level. This manuscript aims to address this knowledge gap and enhance our understanding of genetic interactions and their implications for disease progression.

Pass Reason: All assertions passed</td>
          
        </tr>
        
        <tr>
          
          <td data-content="TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.">TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.</td>
          
          <td data-content="genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits">genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits</td>
          
          <td data-content="starts with context">starts with context</td>
          
          <td data-content="Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms">Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms</td>
          
          <td data-content="[PASS] (0.50)

Transcription-Wide Association Studies (TWAS) are predicated on the examination of how disruptions in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases. These methodologies have proven to be highly effective, not only in elucidating disease etiology at the transcriptome level, but also in predicting disease risk using polygenic scores and in tasks related to drug repurposing. With the widespread availability of gene expression data across various tissues, TWAS has emerged as an efficient approach to identify these biological processes. This method integrates expression quantitative trait loci (eQTLs) data, which provides a mechanistic interpretation for Genome-Wide Association Study (GWAS) findings. However, it&#39;s important to note that TWAS operates at the individual gene level and may not fully capture the complexities of interactions at the network level.

Pass Reason: All assertions passed">[PASS] (0.50)

Transcription-Wide Association Studies (TWAS) are predicated on the examination of how disruptions in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases. These methodologies have proven to be highly effective, not only in elucidating disease etiology at the transcriptome level, but also in predicting disease risk using polygenic scores and in tasks related to drug repurposing. With the widespread availability of gene expression data across various tissues, TWAS has emerged as an efficient approach to identify these biological processes. This method integrates expression quantitative trait loci (eQTLs) data, which provides a mechanistic interpretation for Genome-Wide Association Study (GWAS) findings. However, it's important to note that TWAS operates at the individual gene level and may not fully capture the complexities of interactions at the network level.

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.36)

Transcriptome-wide association studies (TWAS) are a powerful tool for investigating how disturbances in gene regulation can link genetic variations to human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has proven to be remarkably effective not only in deciphering disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (via polygenic scores) [@doi:10.1186/s13059-021-02591-w] and in identifying new uses for existing drugs [@doi:10.1038/nn.4618]. The wealth of gene expression data available across various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9] makes TWAS an advantageous strategy for pinpointing biological processes pertinent to genome-wide association study (GWAS) findings. However, a limitation of TWAS is that it operates at the individual gene level, thereby failing to account for more intricate interactions that occur at the network level. This manuscript addresses this knowledge gap, aiming to enhance our understanding of complex genetic interactions in disease etiology and drug mechanisms.

Pass Reason: All assertions passed">[PASS] (0.36)

Transcriptome-wide association studies (TWAS) are a powerful tool for investigating how disturbances in gene regulation can link genetic variations to human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has proven to be remarkably effective not only in deciphering disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (via polygenic scores) [@doi:10.1186/s13059-021-02591-w] and in identifying new uses for existing drugs [@doi:10.1038/nn.4618]. The wealth of gene expression data available across various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9] makes TWAS an advantageous strategy for pinpointing biological processes pertinent to genome-wide association study (GWAS) findings. However, a limitation of TWAS is that it operates at the individual gene level, thereby failing to account for more intricate interactions that occur at the network level. This manuscript addresses this knowledge gap, aiming to enhance our understanding of complex genetic interactions in disease etiology and drug mechanisms.

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

Transcription-Wide Association Studies (TWAS) serve as a critical tool in exploring the role of genetic variants in human diseases by investigating disruptions in gene regulatory mechanisms [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These studies have been instrumental in deciphering disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], enhancing disease-risk prediction through polygenic scores [@doi:10.1186/s13059-021-02591-w], and facilitating drug repurposing [@doi:10.1038/nn.4618]. With the proliferation of gene expression data across various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], TWAS has proven to be an effective strategy for pinpointing relevant biological processes. It achieves this by integrating Expression Quantitative Trait Loci (eQTLs) data, thereby providing a mechanistic explanation for Genome-Wide Association Studies (GWAS) findings. However, a significant limitation of TWAS is its focus on individual genes, which neglects the potential for more intricate interactions at the network level.

Pass Reason: All assertions passed">[PASS] (0.50)

Transcription-Wide Association Studies (TWAS) serve as a critical tool in exploring the role of genetic variants in human diseases by investigating disruptions in gene regulatory mechanisms [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These studies have been instrumental in deciphering disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], enhancing disease-risk prediction through polygenic scores [@doi:10.1186/s13059-021-02591-w], and facilitating drug repurposing [@doi:10.1038/nn.4618]. With the proliferation of gene expression data across various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], TWAS has proven to be an effective strategy for pinpointing relevant biological processes. It achieves this by integrating Expression Quantitative Trait Loci (eQTLs) data, thereby providing a mechanistic explanation for Genome-Wide Association Studies (GWAS) findings. However, a significant limitation of TWAS is its focus on individual genes, which neglects the potential for more intricate interactions at the network level.

Pass Reason: All assertions passed</td>
          
        </tr>
        
        <tr>
          
          <td data-content="TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.">TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.</td>
          
          <td data-content="genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits">genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits</td>
          
          <td data-content="starts with context">starts with context</td>
          
          <td data-content="Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms">Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms</td>
          
          <td data-content="[PASS] (0.50)

Transcription-Wide Association Studies (TWAS) hinge on investigating if disruptions in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases. Such approaches have proven highly effective not only in elucidating disease etiology at the transcriptome level but also in predicting disease risk through polygenic scores and facilitating drug repurposing tasks. With the widespread availability of gene expression data across numerous tissues, TWAS has emerged as an effective method to identify these biological processes. This technique integrates expression quantitative trait loci (eQTLs) data to offer a mechanistic interpretation of Genome-Wide Association Studies (GWAS) findings. However, it&#39;s important to note that TWAS operates at the individual gene level, thereby failing to capture more complex interactions occurring at the network level.

Pass Reason: All assertions passed">[PASS] (0.50)

Transcription-Wide Association Studies (TWAS) hinge on investigating if disruptions in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases. Such approaches have proven highly effective not only in elucidating disease etiology at the transcriptome level but also in predicting disease risk through polygenic scores and facilitating drug repurposing tasks. With the widespread availability of gene expression data across numerous tissues, TWAS has emerged as an effective method to identify these biological processes. This technique integrates expression quantitative trait loci (eQTLs) data to offer a mechanistic interpretation of Genome-Wide Association Studies (GWAS) findings. However, it's important to note that TWAS operates at the individual gene level, thereby failing to capture more complex interactions occurring at the network level.

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

Transcription-Wide Association Studies (TWAS) are a powerful tool for examining how changes in gene regulation can link genetic variants to human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This method has proven instrumental not only in deciphering the origins of diseases at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk through polygenic scores [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618]. The wealth of gene expression data available across various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9] further enhances the utility of TWAS, as it integrates data from expression quantitative trait loci (eQTLs) to provide mechanistic explanations for Genome-Wide Association Study (GWAS) findings. Despite these advances, a notable limitation of TWAS is that it operates at the level of individual genes, thereby overlooking potentially crucial interactions at the network level. This manuscript addresses this knowledge gap by exploring the potential of more complex network-level interactions.

Pass Reason: All assertions passed">[PASS] (0.50)

Transcription-Wide Association Studies (TWAS) are a powerful tool for examining how changes in gene regulation can link genetic variants to human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This method has proven instrumental not only in deciphering the origins of diseases at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk through polygenic scores [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618]. The wealth of gene expression data available across various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9] further enhances the utility of TWAS, as it integrates data from expression quantitative trait loci (eQTLs) to provide mechanistic explanations for Genome-Wide Association Study (GWAS) findings. Despite these advances, a notable limitation of TWAS is that it operates at the level of individual genes, thereby overlooking potentially crucial interactions at the network level. This manuscript addresses this knowledge gap by exploring the potential of more complex network-level interactions.

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

Transcription-wide association studies (TWAS) are a pivotal tool in understanding the interplay between genetic variants and human diseases, as they examine the impact of changes in gene regulation mechanisms on this relationship [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These studies have proven instrumental not only in comprehending disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (through polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618]. With the abundance of gene expression data across various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], TWAS represents an effective method to identify these biological processes by integrating expression quantitative trait loci (eQTLs) data, thereby offering mechanistic explanations for genome-wide association study (GWAS) findings. However, a critical knowledge gap persists as TWAS primarily focuses on individual genes, thereby overlooking the intricate interactions that occur at the network level.

Pass Reason: All assertions passed">[PASS] (0.50)

Transcription-wide association studies (TWAS) are a pivotal tool in understanding the interplay between genetic variants and human diseases, as they examine the impact of changes in gene regulation mechanisms on this relationship [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These studies have proven instrumental not only in comprehending disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (through polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618]. With the abundance of gene expression data across various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], TWAS represents an effective method to identify these biological processes by integrating expression quantitative trait loci (eQTLs) data, thereby offering mechanistic explanations for genome-wide association study (GWAS) findings. However, a critical knowledge gap persists as TWAS primarily focuses on individual genes, thereby overlooking the intricate interactions that occur at the network level.

Pass Reason: All assertions passed</td>
          
        </tr>
        
        <tr>
          
          <td data-content="TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.">TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.</td>
          
          <td data-content="genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits">genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits</td>
          
          <td data-content="starts with context">starts with context</td>
          
          <td data-content="Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms">Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms</td>
          
          <td data-content="[PASS] (0.50)

Transcription-Wide Association Studies (TWAS) are predicated on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases. These approaches have proven highly successful, not only in understanding disease etiology at the transcriptome level, but also in predicting disease risk through polygenic scores, and in drug repurposing tasks. Given the wide availability of gene expression data across multiple tissues, TWAS provides an effective method to identify these biological processes by integrating Expression Quantitative Trait Loci (eQTLs) data, thereby providing a mechanistic interpretation for Genome-Wide Association Studies (GWAS) findings. However, it&#39;s important to note that TWAS operates at the individual gene level and therefore does not capture more complex interactions at the network level.

Pass Reason: All assertions passed">[PASS] (0.50)

Transcription-Wide Association Studies (TWAS) are predicated on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases. These approaches have proven highly successful, not only in understanding disease etiology at the transcriptome level, but also in predicting disease risk through polygenic scores, and in drug repurposing tasks. Given the wide availability of gene expression data across multiple tissues, TWAS provides an effective method to identify these biological processes by integrating Expression Quantitative Trait Loci (eQTLs) data, thereby providing a mechanistic interpretation for Genome-Wide Association Studies (GWAS) findings. However, it's important to note that TWAS operates at the individual gene level and therefore does not capture more complex interactions at the network level.

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.36)

Transcriptome-wide association studies (TWAS) are pivotal in exploring how changes in gene regulation can link genetic variants to human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These methods have proven effective not only in elucidating disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (using polygenic scores) [@doi:10.1186/s13059-021-02591-w] and in repurposing drugs [@doi:10.1038/nn.4618]. With the abundance of gene expression data across various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], TWAS has become a powerful tool to identify relevant biological processes by integrating expression quantitative trait loci (eQTLs) data, thereby providing mechanistic insights into genome-wide association study (GWAS) results. However, a significant limitation of TWAS is that it operates at the individual gene level, thus failing to capture more intricate interactions at the network level. This manuscript addresses this knowledge gap by exploring the potential of gene co-expression patterns in revealing complex trait clusters, disease etiology, and drug mechanisms.

Pass Reason: All assertions passed">[PASS] (0.36)

Transcriptome-wide association studies (TWAS) are pivotal in exploring how changes in gene regulation can link genetic variants to human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These methods have proven effective not only in elucidating disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (using polygenic scores) [@doi:10.1186/s13059-021-02591-w] and in repurposing drugs [@doi:10.1038/nn.4618]. With the abundance of gene expression data across various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], TWAS has become a powerful tool to identify relevant biological processes by integrating expression quantitative trait loci (eQTLs) data, thereby providing mechanistic insights into genome-wide association study (GWAS) results. However, a significant limitation of TWAS is that it operates at the individual gene level, thus failing to capture more intricate interactions at the network level. This manuscript addresses this knowledge gap by exploring the potential of gene co-expression patterns in revealing complex trait clusters, disease etiology, and drug mechanisms.

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

The study of gene regulatory mechanisms and their impact on human diseases is a critical area of research, often using methodologies such as Transcription-Wide Association Studies (TWAS) [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These methodologies have proven successful in elucidating disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], predicting disease risk through polygenic scores [@doi:10.1186/s13059-021-02591-w], and even repurposing drugs [@doi:10.1038/nn.4618]. The availability of gene expression data across various tissues has further facilitated these studies [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. However, while TWAS has been instrumental in identifying biological processes by integrating expression quantitative trait loci (eQTLs) data to interpret Genome-Wide Association Studies (GWAS) findings, its focus on individual genes limits its ability to capture complex interactions at the network level. This manuscript aims to address this gap by exploring these network-level interactions.

Pass Reason: All assertions passed">[PASS] (0.50)

The study of gene regulatory mechanisms and their impact on human diseases is a critical area of research, often using methodologies such as Transcription-Wide Association Studies (TWAS) [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These methodologies have proven successful in elucidating disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], predicting disease risk through polygenic scores [@doi:10.1186/s13059-021-02591-w], and even repurposing drugs [@doi:10.1038/nn.4618]. The availability of gene expression data across various tissues has further facilitated these studies [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. However, while TWAS has been instrumental in identifying biological processes by integrating expression quantitative trait loci (eQTLs) data to interpret Genome-Wide Association Studies (GWAS) findings, its focus on individual genes limits its ability to capture complex interactions at the network level. This manuscript aims to address this gap by exploring these network-level interactions.

Pass Reason: All assertions passed</td>
          
        </tr>
        
        <tr>
          
          <td data-content="TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.">TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks. Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level.</td>
          
          <td data-content="genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits">genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits</td>
          
          <td data-content="starts with context">starts with context</td>
          
          <td data-content="Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms">Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms</td>
          
          <td data-content="[PASS] (0.50)

Transcription-Wide Association Studies (TWAS) are based on testing the hypothesis that perturbations in gene regulatory mechanisms mediate the link between genetic variants and human diseases. This approach has proven to be highly successful in not only enhancing our understanding of disease etiology at the transcriptome level, but also in predicting disease risk using polygenic scores and in tasks such as drug repurposing. Given the availability of gene expression data across a variety of tissues, TWAS proves to be an effective method for identifying these biological processes. This approach integrates Expression Quantitative Trait Loci (eQTLs) data, providing a mechanistic interpretation for Genome-Wide Association Studies (GWAS) findings. However, it&#39;s important to note that TWAS operates at the level of individual genes and does not capture more complex interactions occurring at the network level.

Pass Reason: All assertions passed">[PASS] (0.50)

Transcription-Wide Association Studies (TWAS) are based on testing the hypothesis that perturbations in gene regulatory mechanisms mediate the link between genetic variants and human diseases. This approach has proven to be highly successful in not only enhancing our understanding of disease etiology at the transcriptome level, but also in predicting disease risk using polygenic scores and in tasks such as drug repurposing. Given the availability of gene expression data across a variety of tissues, TWAS proves to be an effective method for identifying these biological processes. This approach integrates Expression Quantitative Trait Loci (eQTLs) data, providing a mechanistic interpretation for Genome-Wide Association Studies (GWAS) findings. However, it's important to note that TWAS operates at the level of individual genes and does not capture more complex interactions occurring at the network level.

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

Transcription-wide association studies (TWAS) are a powerful tool that determine if changes in gene regulation can explain the link between genetic variations and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has proven successful in not only enhancing our understanding of disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (using polygenic scores) [@doi:10.1186/s13059-021-02591-w] and in identifying new uses for existing drugs [@doi:10.1038/nn.4618]. With the growing availability of gene expression data from various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], TWAS is an effective method for identifying the biological processes involved in these genetic associations. However, a limitation of TWAS is that it operates at the level of individual genes, and therefore, fails to capture the more complex interactions that occur at the network level.

Pass Reason: All assertions passed">[PASS] (0.50)

Transcription-wide association studies (TWAS) are a powerful tool that determine if changes in gene regulation can explain the link between genetic variations and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has proven successful in not only enhancing our understanding of disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (using polygenic scores) [@doi:10.1186/s13059-021-02591-w] and in identifying new uses for existing drugs [@doi:10.1038/nn.4618]. With the growing availability of gene expression data from various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], TWAS is an effective method for identifying the biological processes involved in these genetic associations. However, a limitation of TWAS is that it operates at the level of individual genes, and therefore, fails to capture the more complex interactions that occur at the network level.

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

Transcription-wide association studies (TWAS) are a critical tool in the field of genetics, designed to investigate how disruptions in gene regulation can link genetic variants to human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This method has proven to be highly effective in not only enhancing our understanding of disease origin at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk through polygenic scores [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618]. The widespread availability of gene expression data across various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9] has facilitated the use of TWAS to identify and understand these biological processes. However, a notable limitation of TWAS is its focus on individual genes, which overlooks potentially significant complex interactions occurring at the network level.

Pass Reason: All assertions passed">[PASS] (0.50)

Transcription-wide association studies (TWAS) are a critical tool in the field of genetics, designed to investigate how disruptions in gene regulation can link genetic variants to human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This method has proven to be highly effective in not only enhancing our understanding of disease origin at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk through polygenic scores [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618]. The widespread availability of gene expression data across various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9] has facilitated the use of TWAS to identify and understand these biological processes. However, a notable limitation of TWAS is its focus on individual genes, which overlooks potentially significant complex interactions occurring at the network level.

Pass Reason: All assertions passed</td>
          
        </tr>
        
        <tr>
          
          <td data-content="Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks.">Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks.</td>
          
          <td data-content="genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits">genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits</td>
          
          <td data-content="ends with conclusion">ends with conclusion</td>
          
          <td data-content="Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms">Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms</td>
          
          <td data-content="[PASS] (0.50)

The availability of gene expression data across various tissues has paved the way for the implementation of transcription-wide association studies (TWAS) to identify biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. These studies utilize expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation of GWAS findings. However, TWAS operates at the individual gene level and fails to capture more intricate interactions at the network level. The methodology of TWAS involves testing whether disruptions in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. Despite this limitation, TWAS has been highly successful in not only enhancing our understanding of disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and in drug repurposing tasks [@doi:10.1038/nn.4618].

Pass Reason: All assertions passed">[PASS] (0.50)

The availability of gene expression data across various tissues has paved the way for the implementation of transcription-wide association studies (TWAS) to identify biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. These studies utilize expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation of GWAS findings. However, TWAS operates at the individual gene level and fails to capture more intricate interactions at the network level. The methodology of TWAS involves testing whether disruptions in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. Despite this limitation, TWAS has been highly successful in not only enhancing our understanding of disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and in drug repurposing tasks [@doi:10.1038/nn.4618].

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

The proliferation of gene expression data across various tissues has opened new avenues for understanding biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1038/s1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9] (Context). One such approach is the transcription-wide association study (TWAS), which uses expression quantitative trait loci (eQTLs) data to provide insight into the mechanisms behind findings from genetic studies. TWAS, which tests the role of gene regulation disruptions in the association between genetic variants and human diseases, has proven effective in elucidating disease origins at the transcriptome level and in predicting disease risk. It has also been employed successfully in drug repurposing efforts [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367; @pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433; @doi:10.1186/s13059-021-02591-w; @doi:10.1038/nn.4618] (Content). However, TWAS operates at the level of individual genes, thereby missing potentially significant interactions at the network level, a complexity that this manuscript aims to address (Conclusion).

Pass Reason: All assertions passed">[PASS] (0.50)

The proliferation of gene expression data across various tissues has opened new avenues for understanding biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1038/s1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9] (Context). One such approach is the transcription-wide association study (TWAS), which uses expression quantitative trait loci (eQTLs) data to provide insight into the mechanisms behind findings from genetic studies. TWAS, which tests the role of gene regulation disruptions in the association between genetic variants and human diseases, has proven effective in elucidating disease origins at the transcriptome level and in predicting disease risk. It has also been employed successfully in drug repurposing efforts [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367; @pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433; @doi:10.1186/s13059-021-02591-w; @doi:10.1038/nn.4618] (Content). However, TWAS operates at the level of individual genes, thereby missing potentially significant interactions at the network level, a complexity that this manuscript aims to address (Conclusion).

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

The advancement of technology has enabled the collection of gene expression data from various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. This data is often analyzed using transcription-wide association studies (TWAS), which combine data on gene-expression variations to interpret the results of genome-wide association studies (GWAS). This approach focuses on individual genes, seeking to determine whether changes in gene regulation mechanisms influence the relationship between genetic variations and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This method has proven effective in understanding disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], predicting disease risk through polygenic scores [@doi:10.1186/s13059-021-02591-w], and repurposing drugs [@doi:10.1038/nn.4618]. However, a limitation of TWAS is its inability to account for more complex interactions at the network level, indicating a need for more comprehensive analytical approaches.

Pass Reason: All assertions passed">[PASS] (0.50)

The advancement of technology has enabled the collection of gene expression data from various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. This data is often analyzed using transcription-wide association studies (TWAS), which combine data on gene-expression variations to interpret the results of genome-wide association studies (GWAS). This approach focuses on individual genes, seeking to determine whether changes in gene regulation mechanisms influence the relationship between genetic variations and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This method has proven effective in understanding disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], predicting disease risk through polygenic scores [@doi:10.1186/s13059-021-02591-w], and repurposing drugs [@doi:10.1038/nn.4618]. However, a limitation of TWAS is its inability to account for more complex interactions at the network level, indicating a need for more comprehensive analytical approaches.

Pass Reason: All assertions passed</td>
          
        </tr>
        
        <tr>
          
          <td data-content="Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks.">Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks.</td>
          
          <td data-content="genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits">genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits</td>
          
          <td data-content="ends with conclusion">ends with conclusion</td>
          
          <td data-content="Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms">Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms</td>
          
          <td data-content="[FAIL] (0.21)

Failed
---
The availability of gene expression data across various tissues has paved the way for the identification of biological processes through a method known as the transcription-wide association study (TWAS) [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. TWAS integrates expression quantitative trait loci (eQTLs) data to offer a mechanistic interpretation of GWAS findings. However, it operates at the individual gene level and does not encompass more complex interactions at the network level. TWAS hinges on the testing of whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has proven highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618].

Fail Reason: Failed">[FAIL] (0.21)

Failed
---
The availability of gene expression data across various tissues has paved the way for the identification of biological processes through a method known as the transcription-wide association study (TWAS) [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. TWAS integrates expression quantitative trait loci (eQTLs) data to offer a mechanistic interpretation of GWAS findings. However, it operates at the individual gene level and does not encompass more complex interactions at the network level. TWAS hinges on the testing of whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has proven highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618].

Fail Reason: Failed</td>
          
          <td data-content="[PASS] (0.50)

With the wealth of gene expression data now available across various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], scientists have developed a powerful tool known as the transcription-wide association study (TWAS) to identify and interpret the biological processes underlying genetic associations. This method integrates data from expression quantitative trait loci (eQTLs) to provide a mechanistic explanation for findings from genome-wide association studies (GWAS). However, a limitation of TWAS is its focus on individual genes, which overlooks potential complex interactions that occur at the network level. Despite this, TWAS has been instrumental in probing gene regulatory mechanisms to understand how genetic variants are associated with human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has proven successful not only in elucidating disease causes at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and identifying new uses for existing drugs (drug repurposing) [@doi:10.1038/nn.4618]. However, there remains a need for methods that can capture the complexity of gene interactions at a network level, which this manuscript aims to address.

Pass Reason: All assertions passed">[PASS] (0.50)

With the wealth of gene expression data now available across various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], scientists have developed a powerful tool known as the transcription-wide association study (TWAS) to identify and interpret the biological processes underlying genetic associations. This method integrates data from expression quantitative trait loci (eQTLs) to provide a mechanistic explanation for findings from genome-wide association studies (GWAS). However, a limitation of TWAS is its focus on individual genes, which overlooks potential complex interactions that occur at the network level. Despite this, TWAS has been instrumental in probing gene regulatory mechanisms to understand how genetic variants are associated with human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has proven successful not only in elucidating disease causes at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and identifying new uses for existing drugs (drug repurposing) [@doi:10.1038/nn.4618]. However, there remains a need for methods that can capture the complexity of gene interactions at a network level, which this manuscript aims to address.

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

With the increasing accessibility of gene expression data across various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], researchers have been able to identify key biological processes. One such effective method is the Transcription-Wide Association Study (TWAS), which utilizes expression quantitative trait loci (eQTLs) data to provide a mechanistic explanation for Genome-Wide Association Study (GWAS) results. Despite its success, TWAS operates on an individual gene level, thus failing to capture more intricate interactions at the network level. It focuses on examining if disruptions in gene regulatory mechanisms serve as a bridge between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has been highly effective, not only in understanding disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618]. However, the limitation of TWAS in capturing complex interactions at the network level underscores the need for further research and development in this area.

Pass Reason: All assertions passed">[PASS] (0.50)

With the increasing accessibility of gene expression data across various tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], researchers have been able to identify key biological processes. One such effective method is the Transcription-Wide Association Study (TWAS), which utilizes expression quantitative trait loci (eQTLs) data to provide a mechanistic explanation for Genome-Wide Association Study (GWAS) results. Despite its success, TWAS operates on an individual gene level, thus failing to capture more intricate interactions at the network level. It focuses on examining if disruptions in gene regulatory mechanisms serve as a bridge between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has been highly effective, not only in understanding disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618]. However, the limitation of TWAS in capturing complex interactions at the network level underscores the need for further research and development in this area.

Pass Reason: All assertions passed</td>
          
        </tr>
        
        <tr>
          
          <td data-content="Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks.">Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks.</td>
          
          <td data-content="genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits">genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits</td>
          
          <td data-content="ends with conclusion">ends with conclusion</td>
          
          <td data-content="Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms">Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms</td>
          
          <td data-content="[PASS] (0.50)

The availability of gene expression data across various tissues has paved the way for the implementation of transcription-wide association studies (TWAS) [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. TWAS effectively utilizes expression quantitative trait loci (eQTLs) data, providing a mechanistic interpretation of Genome-Wide Association Studies (GWAS) findings. However, TWAS operates at the individual gene level and does not encompass more intricate network-level interactions. Its methodology involves testing whether disruptions in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. Despite this limitation, TWAS has been highly successful in enhancing our understanding of disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433]. It has also proven valuable in disease-risk prediction using polygenic scores [@doi:10.1186/s13059-021-02591-w] and in tasks related to drug repurposing [@doi:10.1038/nn.4618].

Pass Reason: All assertions passed">[PASS] (0.50)

The availability of gene expression data across various tissues has paved the way for the implementation of transcription-wide association studies (TWAS) [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. TWAS effectively utilizes expression quantitative trait loci (eQTLs) data, providing a mechanistic interpretation of Genome-Wide Association Studies (GWAS) findings. However, TWAS operates at the individual gene level and does not encompass more intricate network-level interactions. Its methodology involves testing whether disruptions in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. Despite this limitation, TWAS has been highly successful in enhancing our understanding of disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433]. It has also proven valuable in disease-risk prediction using polygenic scores [@doi:10.1186/s13059-021-02591-w] and in tasks related to drug repurposing [@doi:10.1038/nn.4618].

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

The wealth of gene expression data now available across a range of tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1038/s1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9] has opened up new avenues for understanding biological processes (Context). One such approach is the transcription-wide association study (TWAS), which employs expression quantitative trait loci (eQTLs) data to provide a mechanistic explanation for findings from genome-wide association studies (GWAS). TWAS has proven highly effective, not only for understanding disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also for predicting disease risk (through polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618] (Content). However, TWAS focuses on individual genes and does not account for more intricate interactions at the network level. Therefore, it is limited in its ability to determine whether changes in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367] (Conclusion).

Pass Reason: All assertions passed">[PASS] (0.50)

The wealth of gene expression data now available across a range of tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1038/s1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9] has opened up new avenues for understanding biological processes (Context). One such approach is the transcription-wide association study (TWAS), which employs expression quantitative trait loci (eQTLs) data to provide a mechanistic explanation for findings from genome-wide association studies (GWAS). TWAS has proven highly effective, not only for understanding disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also for predicting disease risk (through polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618] (Content). However, TWAS focuses on individual genes and does not account for more intricate interactions at the network level. Therefore, it is limited in its ability to determine whether changes in gene regulatory mechanisms mediate the relationship between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367] (Conclusion).

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

The advent of gene expression data across various tissues has opened new avenues for understanding biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. One such approach, the transcription-wide association study (TWAS), leverages expression quantitative trait loci (eQTLs) data to provide a mechanistic explanation for genome-wide association study (GWAS) results. Despite its effectiveness, TWAS focuses on individual genes and does not account for more intricate interactions at the network level. The method tests if alterations in gene regulatory mechanisms are the conduit linking genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. Such strategies have proven highly effective not only in comprehending disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618]. However, the potential to capture complex gene interactions at the network level remains an unexplored frontier, highlighting a knowledge gap that this manuscript aims to address.

Pass Reason: All assertions passed">[PASS] (0.50)

The advent of gene expression data across various tissues has opened new avenues for understanding biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. One such approach, the transcription-wide association study (TWAS), leverages expression quantitative trait loci (eQTLs) data to provide a mechanistic explanation for genome-wide association study (GWAS) results. Despite its effectiveness, TWAS focuses on individual genes and does not account for more intricate interactions at the network level. The method tests if alterations in gene regulatory mechanisms are the conduit linking genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. Such strategies have proven highly effective not only in comprehending disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and repurposing drugs [@doi:10.1038/nn.4618]. However, the potential to capture complex gene interactions at the network level remains an unexplored frontier, highlighting a knowledge gap that this manuscript aims to address.

Pass Reason: All assertions passed</td>
          
        </tr>
        
        <tr>
          
          <td data-content="Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks.">Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks.</td>
          
          <td data-content="genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits">genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits</td>
          
          <td data-content="ends with conclusion">ends with conclusion</td>
          
          <td data-content="Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms">Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms</td>
          
          <td data-content="[PASS] (0.50)

The abundance of gene expression data across various tissues allows for the use of transcription-wide association studies (TWAS) to identify underlying biological processes. This approach integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation of Genome-Wide Association Studies (GWAS) findings. However, TWAS primarily operates on an individual gene level, thereby failing to capture more intricate interactions at the network level. The method hinges on testing whether disruptions in gene regulatory mechanisms mediate the association between genetic variants and human diseases. Despite this limitation, TWAS has proven highly successful in not only understanding disease etiology at the transcriptome level, but also in disease-risk prediction (polygenic scores), and drug repurposing tasks.

Pass Reason: All assertions passed">[PASS] (0.50)

The abundance of gene expression data across various tissues allows for the use of transcription-wide association studies (TWAS) to identify underlying biological processes. This approach integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation of Genome-Wide Association Studies (GWAS) findings. However, TWAS primarily operates on an individual gene level, thereby failing to capture more intricate interactions at the network level. The method hinges on testing whether disruptions in gene regulatory mechanisms mediate the association between genetic variants and human diseases. Despite this limitation, TWAS has proven highly successful in not only understanding disease etiology at the transcriptome level, but also in disease-risk prediction (polygenic scores), and drug repurposing tasks.

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

The availability of gene expression data across various tissues has opened new avenues for understanding biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9] (Context). One effective method is the transcription-wide association study (TWAS), which combines expression quantitative trait loci (eQTLs) data to interpret the mechanisms behind genome-wide association study (GWAS) findings. TWAS investigates if changes in gene regulation mediate the link between genetic variations and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has proven successful in understanding disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w], and repurposing drugs [@doi:10.1038/nn.4618] (Content). However, TWAS operates at the level of individual genes, leaving more intricate network-level interactions unexplored, which points to a crucial gap in our current understanding of disease etiology and drug mechanisms (Conclusion).

Pass Reason: All assertions passed">[PASS] (0.50)

The availability of gene expression data across various tissues has opened new avenues for understanding biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9] (Context). One effective method is the transcription-wide association study (TWAS), which combines expression quantitative trait loci (eQTLs) data to interpret the mechanisms behind genome-wide association study (GWAS) findings. TWAS investigates if changes in gene regulation mediate the link between genetic variations and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has proven successful in understanding disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], predicting disease risk (polygenic scores) [@doi:10.1186/s13059-021-02591-w], and repurposing drugs [@doi:10.1038/nn.4618] (Content). However, TWAS operates at the level of individual genes, leaving more intricate network-level interactions unexplored, which points to a crucial gap in our current understanding of disease etiology and drug mechanisms (Conclusion).

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

With the advent of gene expression data across a range of tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], the scientific community has been equipped with powerful tools to explore biological processes. One such tool is the transcription-wide association study (TWAS), which uses expression quantitative trait loci (eQTLs) data to interpret the results of genome-wide association studies (GWAS) at the molecular level. However, the current TWAS approach operates solely at the level of individual genes, thereby overlooking the potential for more intricate interactions within gene networks. The fundamental premise of TWAS is to examine if changes in gene regulatory mechanisms serve as a bridge between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This method has proven immensely successful not only in elucidating disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (through polygenic scores) [@doi:10.1186/s13059-021-02591-w] and identifying new uses for existing drugs [@doi:10.1038/nn.4618]. However, the inability of TWAS to capture complex network-level interactions underscores a critical gap in our current understanding and application of gene expression data.

Pass Reason: All assertions passed">[PASS] (0.50)

With the advent of gene expression data across a range of tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], the scientific community has been equipped with powerful tools to explore biological processes. One such tool is the transcription-wide association study (TWAS), which uses expression quantitative trait loci (eQTLs) data to interpret the results of genome-wide association studies (GWAS) at the molecular level. However, the current TWAS approach operates solely at the level of individual genes, thereby overlooking the potential for more intricate interactions within gene networks. The fundamental premise of TWAS is to examine if changes in gene regulatory mechanisms serve as a bridge between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This method has proven immensely successful not only in elucidating disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (through polygenic scores) [@doi:10.1186/s13059-021-02591-w] and identifying new uses for existing drugs [@doi:10.1038/nn.4618]. However, the inability of TWAS to capture complex network-level interactions underscores a critical gap in our current understanding and application of gene expression data.

Pass Reason: All assertions passed</td>
          
        </tr>
        
        <tr>
          
          <td data-content="Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks.">Given the availability of gene expression data across several tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9], an effective approach to identify these biological processes is the transcription-wide association study (TWAS), which integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation for GWAS findings. However, TWAS works at the individual gene level, which does not capture more complex interactions at the network level. TWAS relies on testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367], and these approaches have been highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing [@doi:10.1038/nn.4618] tasks.</td>
          
          <td data-content="genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits">genetic studies, functional genomics, gene co-expression, therapeutic targets, drug repurposing, clustering of complex traits</td>
          
          <td data-content="ends with conclusion">ends with conclusion</td>
          
          <td data-content="Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms">Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms</td>
          
          <td data-content="[FAIL] (0.21)

Failed
---
The accessibility of gene expression data across multiple tissues provides an effective approach to identify biological processes through transcription-wide association studies (TWAS) [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. TWAS integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation of GWAS findings. However, TWAS operates on an individual gene level, thereby failing to capture more complex interactions at the network level. The methodology of TWAS involves testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These approaches have proven highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618].

Fail Reason: Failed">[FAIL] (0.21)

Failed
---
The accessibility of gene expression data across multiple tissues provides an effective approach to identify biological processes through transcription-wide association studies (TWAS) [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. TWAS integrates expression quantitative trait loci (eQTLs) data to provide a mechanistic interpretation of GWAS findings. However, TWAS operates on an individual gene level, thereby failing to capture more complex interactions at the network level. The methodology of TWAS involves testing whether perturbations in gene regulatory mechanisms mediate the association between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. These approaches have proven highly successful not only in understanding disease etiology at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in disease-risk prediction (polygenic scores) [@doi:10.1186/s13059-021-02591-w] and drug repurposing tasks [@doi:10.1038/nn.4618].

Fail Reason: Failed</td>
          
          <td data-content="[PASS] (0.50)

With the advent of gene expression data across a multitude of tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1038/s41467-018-03751-6; @doi:10.1186/s13040-020-00216-9], it has become possible to identify key biological processes through transcription-wide association studies (TWAS). This method leverages expression quantitative trait loci (eQTLs) data to shed light on the mechanisms behind genome-wide association study (GWAS) results. However, TWAS operates at the single gene level, thus neglecting potential complex interactions within gene networks. The methodology of TWAS involves testing whether changes in gene regulation can explain the link between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has proven successful in not only understanding disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (through polygenic scores) [@doi:10.1186/s13059-021-02591-w] and identifying new uses for existing drugs (drug repurposing) [@doi:10.1038/nn.4618]. However, the limitation of TWAS in capturing complex gene interactions at the network level signals a gap in our current understanding and methodologies that this manuscript aims to address.

Pass Reason: All assertions passed">[PASS] (0.50)

With the advent of gene expression data across a multitude of tissues [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1038/s41467-018-03751-6; @doi:10.1186/s13040-020-00216-9], it has become possible to identify key biological processes through transcription-wide association studies (TWAS). This method leverages expression quantitative trait loci (eQTLs) data to shed light on the mechanisms behind genome-wide association study (GWAS) results. However, TWAS operates at the single gene level, thus neglecting potential complex interactions within gene networks. The methodology of TWAS involves testing whether changes in gene regulation can explain the link between genetic variants and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367]. This approach has proven successful in not only understanding disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433], but also in predicting disease risk (through polygenic scores) [@doi:10.1186/s13059-021-02591-w] and identifying new uses for existing drugs (drug repurposing) [@doi:10.1038/nn.4618]. However, the limitation of TWAS in capturing complex gene interactions at the network level signals a gap in our current understanding and methodologies that this manuscript aims to address.

Pass Reason: All assertions passed</td>
          
          <td data-content="[PASS] (0.50)

The wealth of gene expression data spanning various tissues provides a rich resource for investigating biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. One effective method for such investigations is the transcription-wide association study (TWAS), which leverages expression quantitative trait loci (eQTLs) data to elucidate the mechanisms underlying genome-wide association study (GWAS) findings. Yet, while TWAS has proven successful in both understanding disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] and in predicting disease risk and identifying potential new uses for existing drugs [@doi:10.1186/s13059-021-02591-w; @doi:10.1038/nn.4618], it operates at the individual gene level and thus overlooks more intricate network-level interactions. This study aims to address the limitations of TWAS by exploring the role of gene regulatory perturbations in the relationship between genetic variations and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367].

Pass Reason: All assertions passed">[PASS] (0.50)

The wealth of gene expression data spanning various tissues provides a rich resource for investigating biological processes [@doi:10.1038/nbt.3838; @doi:10.1038/s41467-018-03751-6; @doi:10.1126/science.aaz1776; @doi:10.1186/s13040-020-00216-9]. One effective method for such investigations is the transcription-wide association study (TWAS), which leverages expression quantitative trait loci (eQTLs) data to elucidate the mechanisms underlying genome-wide association study (GWAS) findings. Yet, while TWAS has proven successful in both understanding disease origins at the transcriptome level [@pmid:33931583; @doi:10.1101/2021.10.21.21265225; @pmid:31036433] and in predicting disease risk and identifying potential new uses for existing drugs [@doi:10.1186/s13059-021-02591-w; @doi:10.1038/nn.4618], it operates at the individual gene level and thus overlooks more intricate network-level interactions. This study aims to address the limitations of TWAS by exploring the role of gene regulatory perturbations in the relationship between genetic variations and human diseases [@doi:10.1371/journal.pgen.1009482; @doi:10.1038/ng.3506; @doi:10.1371/journal.pgen.1007889; @doi:10.1038/ng.3367].

Pass Reason: All assertions passed</td>
          
        </tr>
        
      </tbody>
    </table>
  </body>
</html>
